Earnings by date

Earnings on Friday, March 13, 2026

Every U.S. earnings report scheduled for Friday, March 13, 2026, with the reporting session and consensus estimates for each company.

Last updated Nov 8, 2026 at 7:14 AM ET

FRIDAY · MAR 13

24 reports

ACIUBefore Open
EPS est. $-0.17Rev est. $1.2MReported $-0.13 (+24.3%)
ANVSAfter Close
EPS est. $-0.35Rev est. $0Reported $-0.39 (-11.4%)
BETRAfter Close
EPS est. $-2.18Rev est. $41.5MReported $-2.53 (-15.9%)
BIOXAfter Close
EPS est. $0.07Rev est. $97.9MReported $-0.08 (-212.0%)
BKEBefore Open
EPS est. $1.52Rev est. $400.4MReported $1.59 (+4.6%)
BRNSBefore Open
EPS est. $-0.35Rev est. $0Reported $-0.27 (+23.3%)
BRTBefore Open
EPS est. $-0.16Rev est. $24.4MReported $-0.23 (-46.9%)
CCIRUBefore Open
EPS est. $0.32Rev est. $312.0MReported $0.37 (+14.0%)
CNTYBefore Open
EPS est. $-0.47Rev est. $144.1MReported $-0.61 (-31.2%)
CRVOAfter Close
EPS est. $-0.73Rev est. $859,717Reported $-0.88 (-20.3%)
DLNGBefore Open
EPS est. $0.27Rev est. $37.3MReported $0.34 (+28.2%)
DOUGBefore Open
EPS est. $0.03Rev est. $299.9MReported $-0.17 (-655.6%)
EEXBefore Open
EPS est. $0.05Rev est. $132.5MReported $-0.15 (-429.7%)
KYIVBefore Open
EPS est. $0.32Rev est. $309.0MReported $0.37 (+15.2%)
RLXBefore Open
EPS est. $0.23Rev est. $1.09BReported $0.25 (+7.6%)
SMLRTime TBD
EPS est. $0.04Rev est. $6.8M
STKSBefore Open
EPS est. $0.17Rev est. $218.6MReported $-0.09 (-151.9%)
SVRABefore Open
EPS est. $-0.12Rev est. $0Reported $-0.13 (-8.2%)
TSEOFDuring Market
EPS est. $-2.68Rev est. $780.6MReported $-2.56 (+4.4%)
ULHAfter Close
EPS est. $-0.05Rev est. $379.9MReported $0.14 (+377.2%)
ULYAfter Close
EPS est. $-3.10Rev est. $32.1MReported $-1.97 (+36.4%)
VEONBefore Open
EPS est. $1.12Rev est. $1.14BReported $-0.44 (-139.2%)
BMXITime TBD
EPS est. -Rev est. -
BUKSTime TBD
EPS est. -Rev est. -

Free by email

Get the week ahead by email

One free email each week: the earnings and economic releases that matter, when they land, and what the market is watching.

Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.